Skin and muscle permeating antibacterial nanoparticles for treating Staphylococcus aureus infected wounds

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 104, Issue 4, 2016, Pages 797-807

  Dhanalakshmi, V ^a   Nimal, T R ^a   Sabitha, M ^b   Biswas, Raja ^a   Jayakumar, R ^a  

^a AMRITA SCHOOL OF ARTS AND SCIENCES   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

bacterial wound infection; chitosan nanoparticles; lecithin; tigecycline; tissue penetration

Indexed keywords

ANTIBIOTICS; BACTERIA; CHITIN; CHITOSAN; LECITHIN; MUSCLE; NANOPARTICLES; PERMEATION;

ANTI-BACTERIAL ACTIVITY; CHITOSAN NANOPARTICLES; DELIVERY SYSTEMS; STAPHYLOCOCCUS AUREUS; SUSTAINED RELEASE; TIGECYCLINE; TISSUE PENETRATIONS; WOUND INFECTIONS;

TISSUE;

CHITOSAN NANOPARTICLE; PHOSPHATIDYLCHOLINE; TIGECYCLINE; CHITOSAN; DRUG CARRIER; MINOCYCLINE; NANOPARTICLE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BIOCOMPATIBILITY; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOCOMPATIBILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; EX VIVO STUDY; HEMOCOMPATIBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MUSCLE; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SKIN; STAPHYLOCOCCUS INFECTION; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; WOUND INFECTION; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; METABOLISM; MICROBIOLOGY; PIG; SKELETAL MUSCLE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; MICE; MINOCYCLINE; MUSCLE, SKELETAL; NANOPARTICLES; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; SWINE; WOUND INFECTION;

EID: 84969375527     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33635     Document Type: Conference Paper

References (49)

1. Guo S, DiPietro LA., Factors affecting wound healing. J Dent Res 2010; 89: 219-229.
2. Eming SA, Krieg T, Davidson JM., Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol 2007; 127: 514-525.
3. Jacobsen JN, Andersen AS, Sonnested MK, Laursen I, Jorgensen B, Krogfelt KA., Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa. Int Wound J 2011; 8: 33-43.
4. Tennvall GR, Apelqvist J., Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004; 39: S132-S139.
5. Browne AC, Vearncombe M, Sibbald RG., High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001; 47: 44-49.
6. Olson MW, Ruzin A, Feyfant E, Rush TS, O'Connell J, Bradford PA., Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother 2006; 50: 2156-2166.
7. Saettone MF, Salminen L., Ocular inserts for topical delivery. Adv Drug Deliv Rev 1995; 16: 95-106.
8. Singh R, Lillard JW., Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009; 86: 215-223.
9. Kumari A, Yadav SK, Yadav SC., Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010; 75: 1-18.
10. Kim MH, Yamayoshi I, Mathew S, H Lin, J Nayfach, SI Simon,. Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection. Ann. Biomed. Eng 2013; 41: 598-609.
11. Gunasekaran T, Nigusse T, Dhanaraju MD., Silver nanoparticles as real topical bullets for wound healing. J Am Coll Clin Wound Spec 2011; 3: 82-96.
12. Jain D, Banerjee R., Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater 2008; 86: 105-112.
13. Jayakumar R, Menon D, Manzoor K, Nair SV, Tamura H., Biomedical applications of chitin and chitosan based nanomaterials-A short review. Carbohydr Polym 2010; 82: 227-232.
14. Jayakumar R, Prabaharan M, Kumar PTS, Nair SV, Tamura H., Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 2011; 29: 322-337.
15. Sonvico F, Cagnani A, Rossi A, Motta S, Di Bari M, Cavatorta F, Alonso M, Deriu A, Colombo P., Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm 2006; 324: 67-73.
16. Xu Q, Nakajima M, Shiina T, Liu Z., Soybean-based surfactants and their applications. INTECH Open Access Publisher 2011; DOI: 10.5772/15261.
17. López-León T, Carvalho E, Seijo B, Ortega-Vinuesa J, Bastos-González D., Physicochemical characterization of chitosan nanoparticles: Electrokinetic and stability behavior. J Colloid Interface Sci 2005; 283: 344-351.
18. Schreml S, Szeimies RM, Karrer S, Heinlin J, Landthaler M, Babilas P., The impact of the pH value on skin integrity and cutaneous wound healing. J Eur Acad Dermatol Venereol 2010; 24: 373-378.
19. Anitha A, Rani VD, Krishna R, Sreeja V, Selvamurugan N, Nair SV, Tamura H, Jayakumar R., Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N, O-carboxymethyl chitosan nanoparticles. Carbohydr Polym 2009; 78: 672-677.
20. Jayakumar R, Chennazhi KP, Muzzarelli R, Tamura H, Nair SV, Selvamurugan N., Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr Polym 2010; 79: 1-8.
21. Anitha A, Deepagan V, Rani VD, Menon D, Nair SV, Jayakumar R., Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr Polym 2011; 84: 1158-1164.
22. Narayanan D, Anitha A, Jayakumar R, Nair SV, Chennazhi K., Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis. J Biomed Nanotechnol 2012; 8: 98-106.
23. Singhvi G, Singh M., Review: in-vitro drug release characterization models. Int J Pharm Stud Res 2011; 2: 77-84.
24. Kumar PTS, Lakshmanan VK, Biswas R, Nair SV, Jayakumar R., Synthesis and biological evaluation of chitin hydrogel/nano ZnO composite bandage as antibacterial wound dressing. J Biomed Nanotechnol 2012; 8: 891-900.
25. Maya S, Indulekha S, Sukhithasri V, Smitha KT, Nair SV, Jayakumar R, Biswas R., Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int J Biol Macromol 2012; 51: 392-399.
26. Marina AD, Jeffrey DC, Barry WN, Jennifer BH, Anil KP, Scott EM,. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 2008; 8: 2180-2187.
27. Kiruthika V, Maya S, Suresh M K, Kumar V A, Jayakumar R, Biswas R., Comparative efficacy of chloramphenicol loaded chondroitin sulfate and dextran sulfate nanoparticles to treat intracellular Salmonella infections. Colloids Surf B Biointerfaces 2015; 127: 33-40.
28. Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, Gotz F., Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett 2006; 259: 260-268.
29. Mohandas A, Nimal TR, Vishnu D, Shankarappa SA, Biswas R, Jayakumar R., Drug loaded bi-layered sponge for wound management in hyperfibrinolytic conditions. J Mater Chem B 2015; 3: 5795-5805.
30. Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, Friedman AJ, Nosanchuk JD, Friedman JM., Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infections. J Invest Dermatol 2009; 129: 2463-2469.
31. Shi Z, Neoh K, Kang E, Wang W., Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 2006; 27: 2440-2449.
32. 2 nanoparticles and nanowires in ex vivo porcine skin model. J Biomed Nanotechnol 2014; 10: 864-870.
33. Lboutounne H, Chaulet J-F, Ploton C, Falson F, Pirot F., Sustained ex vivo skin antiseptic activity of chlorhexidine in poly (ϵ-caprolactone) nanocapsule encapsulated form and as a digluconate. J. Control Release 2002; 82: 319-334.
34. Smitha K, Nisha N, Maya S, Biswas R, Jayakumar R., Delivery of rifampicin-chitin nanoparticles into the intracellular compartment of polymorphonuclear leukocytes. Int. J Biol Macromol 2015; 74: 36-43.
35. Sapino S, Ugazio E, Gastaldi L, Miletto I, Berlier G, Zonari D, Oliaro-Bosso S., Mesoporous silica as topical nanocarriers for quercetin: Characterization and in vitro studies. Eur J Pharm Biopharm 2015; 89: 116-125.
36. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N, Patil N., Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009; 10: 289-296.
37. Özgüney IS, Karasulu HY, Kantarci G, Sözer S, Güneri T, Ertan G., Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 2006; 7: E39-E45.
38. Diebold Y, Jarrín M, Saez V, Carvalho EL, Orea M, Calonge M, Seijo B, Alonso MJ., Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007; 28: 1553-1564.
39. Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A., Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002; 243: 93-105
40. Şenyiǧit T, Sonvico F, Barbieri S, Özer Ö, Santi P, Colombo P., Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010; 142: 368-373.
41. Alphonsa BM, Kumar PTS, Praveen G, Biswas R, Chennazhi KP, Jayakumar R., Antimicrobial drugs encapsulated in fibrin nanoparticles for treating microbial infested wounds. Pharm. Res 2014; 31: 1338-1351.
42. Devika RB, Varsha BP., Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note. AAPS PharmSciTech 2006; 7: E138-E143.
43. Kong XG, Xing CK, Park HJ,. Antimicrobial properties of chitosan and mode of action: A state of the art review. Int J Food Microbiol 2010; 144: 51-63.
44. Hoban DJ, Bouchillon SK, Johnson BM, Johnson JL, Dowzicky MJ., Tigecycline Evaluation and Surveillance Trial (TEST Program) Group, In vitro activity of tigecycline against 6,792 Gram-negative and Gram-positive clinical isolates from the global tigecycline evaluation and surveillance trial (TEST Program; 2004). Diagn Microbiol Infect Dis 2005; 52: 215-227.
45. Dai T, Tanaka M, Huang YY, Hamblin MR., Chitosan preparations for wounds and burns: Antimicrobial and wound healing effects. Exp Rev Anti Infect Ther 2011; 9: 857-879.
46. Gerelli Y, Barbieri S, Di Bari M, Deriu A, Cantu L, Brocca P, Sonvico F, Colombo P, May R, Motta S., Structure of self-organized multilayer nanoparticles for drug delivery. Langmuir 2008; 24: 11378-11384.
47. Schneider M, Stracke F, Hansen S, Schaefer UF., Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 2009; 1: 197-206.
48. Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R., Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012; 4: 239-250.
49. Schäfer-Korting M, Mehnert W, Korting HC., Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007; 59: 427-443.